Lawrence Stuesser insider trades: Integramed America (INMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lawrence reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 14, 2011 | INMD | ↓ Sell | 743 | $9.50 | $7K | Direct | Jun 16, 2011 (2d) |
| Jun 13, 2011 | INMD | ↓ Sell | 793 | $9.50 | $8K | Direct | Jun 14, 2011 (1d) |
| Nov 22, 2005 | ACR | ↓ Sell | 15,000 | $23.45 | $352K | Direct | Nov 23, 2005 (1d) |
| Sep 6, 2005 | INMD | ↓ Sell | 3,900 | $12.79 | $50K | Direct | Sep 7, 2005 (1d) |
| Aug 24, 2005 | INMD | ↓ Sell | 1,250 | $13.28 | $17K | Direct | Aug 24, 2005 (0d) |
| Aug 23, 2005 | INMD | ↓ Sell | 3,000 | $12.42 | $37K | Direct | Aug 24, 2005 (1d) |
| Aug 12, 2005 | INMD | ↓ Sell | 12,000 | $10.55 | $127K | Direct | Aug 15, 2005 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lawrence Stuesser's insider trades
Lawrence Stuesser is a director at Integramed America (INMD). Since Aug 12, 2005, Lawrence has reported no open-market purchases and 7 sales worth $597K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), option exercises (8 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.